secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2026-05-05T23:59:59+00:00
Accession:  0001193125-26-204982
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q1 GAAP EPS $0.36, Adj. EPS $0.44; revenue $476M, beat expectations
-----------------------------------------------------------------------------

- Net revenue $476.2M, up 4% YoY from $458.4M; same-unit revenue grew 2.8%.
- Adjusted EBITDA $58.2M vs $49.2M YoY; net income $29.6M ($0.36 diluted) vs $20.7M ($0.24).
- Same-unit volume down 1.6% (hospital services -1.5%, office -3.3%) but reimbursement up 4.4%.
- Reaffirmed FY2026 Adjusted EBITDA guidance range of $280M-$300M.
- Used $21.5M for share repurchases and $7.0M for acquisitions in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000119312526204982/0001193125-26-204982-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000119312526204982/md-20260505.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-204982

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer